Skip to main content

Table 1 COX-2 selective inhibitors currently marketed in some European, North American, and Latin American countries

From: COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients

Generic name

Proprietary name

Manufacturer

celecoxib

Celebrex

Pharmacia Corporation and Pfizer, Inc

etoricoxib

Arcoxia

Merck & Co, Inc

rofecoxib

Vioxx

Merck & Co, Inc

valdecoxib

Bextra

Pharmacia Corporation and Pfizer, Inc